Diabetic Kidney Disease: Evidence from Two Selected Cohorts of Patients from Low-Middle and High Income Countries

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objectives: Diabetic kidney disease (DKD) is the leading cause of kidney failure worldwide. Different phenotypes of DKD are emerging, partially attributable to a better glycemic control, partially to concomitant risk factors for kidney disease. Diabetes belongs to Non-Communicable Diseases (NCD), but poor data about DKD in Low-Middle Income Countries are currently available. In the present paper we compare two cohorts of patients affected by DKD from Tanzania and from Italy. Study design: Retrospective observational study conducted by NCDs Clinic of Tosamaganga Regional Referral Hospital (Tanzania) and from the Multidisciplinary Diabetological-Nephrological Clinic of Bologna (Italy) Methods: Included patients’data were analyzed for demographical features, diabetes complications, laboratory findings and pharmacological therapy at the time of enrollment and after 6-month follow up. Results: Tanzanian patients were younger (56.65 vs 67.66 years, p< 0.001), with a higher prevalence of women (66.9% vs 25.5%, p< 0.001) and showed lower level of BMI (26.39 vs 30.18 kg/m2, p< 0.001). A worsen glycemic control could be observed in Tanzanian cohort (HbA1c 83.71 vs 56.92 mmol/mol, p< 0.001) and higher eGFR (70.13±31.93 vs 52.31±23.37 ml/min, p< 0.001). A sharp reduction of albuminuria was observed in both cohorts with an increase in nephroprotective drugs a better glycemic control. Conclusions: Two phenotypes of diabetic patients have emerged from comparison between two cohorts. Tanzanian patients are mostly female, younger and with normal BMI; whereas Italian patients are mainly male, older and affected by metabolic syndrome and vascular complications. Therapy implementation is associated with a delayed decline of eGFR and downgrading of albuminuria at 6 months follow up.

Article activity feed